Personalizing Treatment Delivery
Key facts
- Who runs it
- Rutgers, The State University of New Jersey
- Where
- Piscataway, United StatesSee the site
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 81 people, planned
- Started
- 21 Oct 2024
- Expected to end
- 1 Jul 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Personalized intervention condition: Cognitive behavioral therapy skills
- Therapeutic control condition: Cognitive behavioral therapy skills
- Tracking control condition: Supportive counseling
- Record updated
- 30 July 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Access to a smart phone
- Between 18 and 65 years
- Clinically significant anxiety or trauma-related symptoms
- Alcohol use problems
- Interest in telehealth counseling
- Anticipated New Jersey or New York residence for the duration of the study
Who cannot take part
- Currently receiving individual counseling or counseling at a higher level of care
- Psychiatric medication that is not currently at a stable dose (or is not anticipated to remain at a stable dose for the duration of the study)
- Demonstrated indicators of more intensive or acute care
- Temporary residence within the state of New Jersey or New York or out-of-state residence from the state of New Jersey or New York
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- Rutgers - Robert Wood Johnson Medical SchoolPiscataway, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Anxiety and anxiety-related disorders frequently co-occur with alcohol use problems resulting in an enormous humanitarian and economic cost to society. The proposed research will use digital technology to examine person-specific risk factors predicting problematic alcohol use in individuals vulnerable to anxiety and anxiety-related disorders and will use this information to design a personalized intervention for individuals seeking psychological treatment. Results from this research will integrate output from novel and innovative digital technology methods into psychotherapy, advancing research on personalized treatment and prevention efforts.
The 3 groups in the trial
- Personalized intervention conditionTreatment being tested
This experimental condition will test a data-driven, person-specific intervention using CBT skills.
Treatment: Personalized intervention condition: Cognitive behavioral therapy skills
- Therapeutic control conditionExisting treatment, for comparison
This control condition will provide an experimental comparison to test the process of personalization.
Treatment: Therapeutic control condition: Cognitive behavioral therapy skills
- Tracking control conditionExisting treatment, for comparison
This second control condition will provide an experimental comparison to test the effects of health-related tracking and therapeutic contact.
Treatment: Tracking control condition: Supportive counseling
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Digital Phenotyping of Anxiety and Anxiety-Related Alcohol Comorbidity and Treatment
- Criteria questions
- Built from NCT05821634, who can take part
- Record updated
- 30 July 2026